On 15 April 1999, physician Gillian Thomas published the editorial “Improved Treatment for Cervical Cancer – Concurrent Chemotherapy and Radiotherapy,” henceforth “Improved Treatment,” in The New England Journal of Medicine. In that editorial, she discusses the potential benefits of combining chemotherapy drugs with radiation to treat women with cervical cancer. At the time, healthcare professionals rarely treated cervical cancer by combining chemotherapy or radiation. Two months prior to Thomas’s publication, the US National Cancer Institute, headquartered in Bethesda, Maryland, released an announcement advocating for combining chemotherapy with radiation based on clinical trial results. In “Improved Treatment,” Thomas summarized the results of those clinical trials that had led to the announcement and communicated a new way to treat invasive cervical cancers, which persists as of 2019.
Menopause is defined as the point in time exactly twelve months after a female has had her last menstrual period, or shedding of the lining of the uterus. As a female ages, the hormone levels that drive menstruation decrease, beginning the process of perimenopause, which eventually leads to menopause and can result in various symptoms including depression, difficulty sleeping, and hot flashes, or abrupt feelings of heat typically in the upper body. Once a female reaches menopause, those symptoms typically subside, but after menopause, the risk of other health conditions such as osteoporosis, or brittle bones, increases. At least since the fourth century BCE, researchers understood that menopause occurred in females but held many negative ideas and misconceptions about the process, which resulted in stigma that left females uninformed about what happened to their bodies as they aged. Research on and perceptions towards menopause evolved over the twentieth century, and as of 2024, researchers understand it as a typical part of aging and development in females, marking the end of their reproductive years.